ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

DARAPRIM
Malaria
Protozoal infections
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

DARAPRIM Rx

Generic Name and Formulations:
Pyrimethamine 25mg; scored tabs.

Company:
Turing Pharmaceuticals LLC

Therapeutic Use:

Indications for DARAPRIM:

Treatment of acute malaria in combination with other antimalarials only. Chemoprophylaxis of malaria due to susceptible strains of plasmodia.

Adults and Children:

Acute treatment: Monotherapy not recommended, must give with concomitant fast-acting schizonticides (eg, chloroquine, quinine). 25mg daily for 2 days with a sulfonamide. Monotherapy in semi-immune adult patients (should circumstances arise): 50mg daily for 2 days; children 4–10yrs: 25mg daily for 2 days. Chemoprophylaxis: <4yrs: 6.25mg once weekly. 4–10yrs: 12.5mg once weekly. >10yrs: 25mg once weekly. Regimens which include suppression should be extended through any characteristic periods of early recrudescence and late relapse, for at least 10 weeks in each case.

Contraindications:

Megaloblastic anemia due to folate deficiency.

Warnings/Precautions:

Renal or hepatic impairment. Folate deficiency (eg, malabsorption syndrome, alcoholism, pregnancy, concomitant phenytoin). Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Increased risk of bone marrow suppression with concomitant antifolic drugs or agents associated with myelosuppression (eg, sulfonamides, trimethoprim-sulfamethoxazole combinations, proguanil, zidovudine, methotrexate). Mild hepatotoxicity with lorazepam.

Pharmacological Class:

Folic acid antagonist.

Adverse Reactions:

Hypersensitivity reactions (may be severe: Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, anaphylaxis; discontinue if occurs), hyperphenylalaninemia, hematologic effects; rare: pulmonary eosinophilia. May be carcinogenic.

Generic Availability:

NO

How Supplied:

Tabs—30, 100

Indications for DARAPRIM:

Treatment of toxoplasmosis when used conjointly with a sulfonamide.

Adult:

Give concomitant folinic acid. Initially 50–75mg daily, together with 1–4g daily of a sulfonamide of the sulfapyramidine type (eg, sulfadoxine). Continue for 1–3 weeks depending on response and tolerance. May reduce dose by ½ and continue for additional 4–5 weeks.

Children:

Give concomitant folinic acid and usual pediatric sulfonamide dose. 1mg/kg divided into 2 equal doses; after 2–4 days, may reduce dose by ½ and continue for 1 month.

Contraindications:

Megaloblastic anemia due to folate deficiency.

Warnings/Precautions:

Renal or hepatic impairment. Folate deficiency (eg, malabsorption syndrome, alcoholism, pregnancy, concomitant phenytoin); reduce dose or discontinue drug if develops. Seizure disorders: give small starting dose to avoid CNS toxicity. Obtain semi-weekly blood counts, including platelets. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Increased risk of bone marrow suppression with concomitant antifolic drugs or agents associated with myelosuppression (eg, sulfonamides, trimethoprim-sulfamethoxazole combinations, proguanil, zidovudine, methotrexate). Mild hepatotoxicity with lorazepam.

Pharmacological Class:

Folic acid antagonist.

Adverse Reactions:

Hypersensitivity reactions (may be severe: Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, anaphylaxis; discontinue if occurs), hyperphenylalaninemia, hematologic effects (eg, megaloblastic anemia, leukopenia, thrombocytopenia, pancytopenia, neutropenia), atrophic glossitis, hematuria, cardiac rhythm disorders; rare: pulmonary eosinophilia. May be carcinogenic.

Generic Availability:

NO

How Supplied:

Tabs—30, 100

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs